Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Dunder

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Internal Medicine|January 30, 2004
A new Q/QS pattern on the resting electrocardiogram is associated with impaired insulin secretion and a poor prognosis in elderly men independently of history of myocardial infarctionK Dunder, L Lind, B Zethelius, et al.
Diabetologia|December 15, 2010
Rosiglitazone: a European regulatory perspectiveE Blind, K Dunder, P A de Graeff, et al.
Archives of Dermatological Research|April 9, 1999
Identification and characterization of multiple forms of tryptase from human mast cellsR J Harvima, I T Harvima, D Dull, et al.
ESMO Open|January 5, 2021
The European Medicines Agency review of the initial application of atezolizumab and the role of PD-L1 expression as biomarker for checkpoint inhibitorsI Araujo-Fernandez, J Delgado, L Moscetti, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Internal Medicine|January 30, 2004
A new Q/QS pattern on the resting electrocardiogram is associated with impaired insulin secretion and a poor prognosis in elderly men independently of history of myocardial infarctionK Dunder, L Lind, B Zethelius, et al.
Diabetologia|December 15, 2010
Rosiglitazone: a European regulatory perspectiveE Blind, K Dunder, P A de Graeff, et al.
Archives of Dermatological Research|April 9, 1999
Identification and characterization of multiple forms of tryptase from human mast cellsR J Harvima, I T Harvima, D Dull, et al.
ESMO Open|January 5, 2021
The European Medicines Agency review of the initial application of atezolizumab and the role of PD-L1 expression as biomarker for checkpoint inhibitorsI Araujo-Fernandez, J Delgado, L Moscetti, et al.
Pageof 1